DarioHealth (NASDAQ:DRIO – Get Free Report) will likely be releasing its earnings data before the market opens on Monday, March 10th. Analysts expect DarioHealth to post earnings of ($0.16) per share and revenue of $7.39 million for the quarter. Persons that are interested in registering for the company’s earnings conference call can do so using this link.
DarioHealth Stock Performance
NASDAQ DRIO opened at $0.73 on Friday. The company has a current ratio of 1.57, a quick ratio of 1.32 and a debt-to-equity ratio of 0.35. The firm has a market capitalization of $30.28 million, a price-to-earnings ratio of -0.78 and a beta of 1.42. The firm’s 50 day simple moving average is $0.73 and its 200 day simple moving average is $0.82. DarioHealth has a 1 year low of $0.56 and a 1 year high of $1.93.
Wall Street Analyst Weigh In
Separately, TD Cowen lowered shares of DarioHealth from a “buy” rating to a “hold” rating and reduced their price target for the stock from $2.00 to $1.00 in a research report on Wednesday, January 29th.
About DarioHealth
DarioHealth Corp. operates as a digital health company in the United States, Canada, the European Union, Australia, and New Zealand. Its digital therapeutics platform and suite of solutions deliver personalized and dynamic interventions driven by data analytics and one-on-one coaching for diabetes, hypertension, weight management, musculoskeletal pain, and behavioral health.
Read More
- Five stocks we like better than DarioHealth
- Market Cap Calculator: How to Calculate Market Cap
- These 4 Tech ETFs Just Hit 50-Day Lows—Time to Buy?
- High Flyers: 3 Natural Gas Stocks for March 2022
- 3 Stocks to Buy While Others Stay on the Sidelines
- Technology Stocks Explained: Here’s What to Know About Tech
- MarketBeat Week in Review – 03/03 – 03/07
Receive News & Ratings for DarioHealth Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DarioHealth and related companies with MarketBeat.com's FREE daily email newsletter.